Aug 24, 2022 | Cancer Center News
Stephen G. Sligar has spent the last 40 years at the University of Illinois Urbana-Champaign applying his expertise in membrane proteins and his nanodisc technology to better understand biological pathways and address diseases including cancer. Urbana, Ill. – Stephen...
Jul 6, 2022 | Cancer Center News
The research team included Yo-Chuen Lin (bottom left) and Dazhen Liu (bottom right), along with Professors Supriya Prasanth (above) and KV Prasanth. Urbana, Ill. – Initiation of DNA duplication requires a six-subunit complex, the Origin Recognition Complex (ORC) that...
Jun 23, 2022 | Cancer Center News
MYC promotes POLR3G gene expression, shaping Pol III identity and downstream transcription activities associated with cell proliferation. Urbana, Ill. – Researchers at the University of Illinois Urbana-Champaign and Stanford University School of Medicine have...
May 18, 2022 | Cancer Center News
Photo of Van Bortle Lab members. From left to right: Sihang Zhou, Ruiying Cheng, Rajendra K C, and Kevin Van Bortle. Urbana, Ill. – Kevin Van Bortle has been interested in chromatin and transcription dynamics since the start of his research career as a graduate...
Feb 15, 2022 | Cancer Center News
Image of Brian Freeman. Urbana, Ill. – Cancer Center at Illinois scientist and professor of cell and developmental biology, Brian Freeman, has focused his research on the study of molecular chaperones (MCs) since the beginning of his career as a graduate student when...
Nov 17, 2021 | Cancer Center News
Image of Hong Jin. Urbana, Ill. – Over the past year, the Hong Jin lab at the University of Illinois has been focusing on a potential oncogene, developmentally-regulated GTP-ase (Drg1), and its function in tumor progression. A recent, critical decision to examine...
Nov 10, 2020 | Cancer Center News
Current cancer treatments include drugs that target standard protein synthesis in cells, which can kill cancer cells, but also targets healthy cells. To address this issue, Cancer Center at Illinois (CCIL) member and professor of biophysics and quantitative biology,...
Jun 30, 2020 | Cancer Center News
CHAMPAIGN, Ill. — A method known as CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia. It modifies a patient’s own T-cells by adding a piece of an antibody that recognizes unique features on the surface of cancer...
Nov 4, 2019 | Cancer Center News
Kai Zhang CCIL member Kai Zhang , professor of biochemistry, developed a novel optogenetic technique, called GLIMPSe, to use light to control and stabilize the lifetime of intracellular proteins. Zhang stated that this method is a nontoxic and more efficient way to...
